BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32306375)

  • 21. Novel Autoantigens Associated with Lupus Nephritis.
    Onishi S; Adnan E; Ishizaki J; Miyazaki T; Tanaka Y; Matsumoto T; Suemori K; Shudou M; Okura T; Takeda H; Sawasaki T; Yasukawa M; Hasegawa H
    PLoS One; 2015; 10(6):e0126564. PubMed ID: 26098692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence.
    Bruschi M; Angeletti A; Prunotto M; Meroni PL; Ghiggeri GM; ; Moroni G; Sinico RA; Franceschini F; Fredi M; Vaglio A; Cavalli A; Scapozza L; Patel JJ; Tan JC; Lo KC; Cavagna L; Petretto A; Pratesi F; Migliorini P; Locatelli F; Pazzola G; Pesce G; Giannese D; Manfredi A; Ramirez GA; Esposito P; Murdaca G; Negrini S; Bui F; Trezzi B; Emmi G; Cavazzana I; Binda V; Fenaroli P; Pisan I; Montecucco C; Santoro D; Scolari F; Mescia F; Volpi S; Mosca M; Tincani A; Ravelli A; Murtas C; Candiano G; Caridi G; La Porta E; Verrina E
    Autoimmun Rev; 2024 May; 23(5):103535. PubMed ID: 38552995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serological and histological study of lupus nephritis with special reference to anti-SSA antibody].
    Nakashima A
    Nihon Jinzo Gakkai Shi; 1989 Jul; 31(7):743-55. PubMed ID: 2585828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-DFS70 Antibodies Are Associated With Proliferative Lupus Nephritis and Renal Pathological Activity.
    Chen D; Zhao L; Dai Y; Du F; Li E; Niu X; Wang Z; Zheng B; Lu L
    Front Immunol; 2022; 13():810639. PubMed ID: 35185903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies Against C3b-Functional Consequences and Disease Relevance.
    Vasilev VV; Radanova M; Lazarov VJ; Dragon-Durey MA; Fremeaux-Bacchi V; Roumenina LT
    Front Immunol; 2019; 10():64. PubMed ID: 30761135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological aspects of biopsy-proven lupus nephritis in Bahraini patients with systemic lupus erythematosus.
    Farid EM; Hassan AB; Abalkhail AA; El-Agroudy AE; Arrayed SA; Al-Ghareeb SM
    Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1271-9. PubMed ID: 24231503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients.
    Martin M; Trattner R; Nilsson SC; Björk A; Zickert A; Blom AM; Gunnarsson I
    Front Immunol; 2020; 11():582737. PubMed ID: 33133102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis.
    Hung WT; Chen YM; Lan JL; Chen HH; Chen YH; Chen DY; Hsieh CW; Wen MC
    Lupus; 2011 Nov; 20(13):1404-10. PubMed ID: 21946514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD; Patwardhan MM; Ghosh K
    Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibodies Targeting Ficolin-2 in Systemic Lupus Erythematosus Patients With Active Nephritis.
    Colliard S; Jourde-Chiche N; Clavarino G; Sarrot-Reynauld F; Gout E; Deroux A; Fougere M; Bardin N; Bouillet L; Cesbron JY; Thielens NM; Dumestre-Pérard C
    Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1263-1268. PubMed ID: 29045037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers.
    Akhter E; Burlingame RW; Seaman AL; Magder L; Petri M
    Lupus; 2011 Oct; 20(12):1267-74. PubMed ID: 21813587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus.
    Orjuela A; Suwanichkul A; Canter D; Minard CG; Devaraj S; Hicks MJ; Muscal E; Wenderfer SE
    Am J Nephrol; 2015; 41(3):241-7. PubMed ID: 25926050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single anti-P ribosomal antibodies are not associated with lupus nephritis in patients suffering from active systemic lupus erythematosus.
    Quintana G; Coral-Alvarado P; Aroca G; Patarroyo PM; Chalem P; Iglesias-Gamarra A; Ruiz AI; Cervera R
    Autoimmun Rev; 2010 Sep; 9(11):750-5. PubMed ID: 20601199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies in lupus nephritis patients requiring renal transplantation.
    Stinton LM; Barr SG; Tibbles LA; Yilmaz S; Sar A; Benedikttson H; Fritzler MJ
    Lupus; 2007; 16(6):394-400. PubMed ID: 17664229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-RNP antibodies are associated with the interferon gene signature but not decreased complement levels in SLE.
    Hubbard EL; Pisetsky DS; Lipsky PE
    Ann Rheum Dis; 2022 May; 81(5):632-643. PubMed ID: 35115332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
    Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
    Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.